Skip to main content

COVID-19 Advisory: Visitor restrictions are in place for all Phoenix Children’s locations. Masks are required for all visitors and for patients ages 2+. For more information, visit our COVID-19 Resource Center.

Carla Allan

Carla C. Allan, PhD

Edit Profile

Chief, Psychology; Hagenah Family Endowed Chair, Psychology

Carla C. Allan, PhD

Edit Profile

Chief, Psychology; Hagenah Family Endowed Chair, Psychology

Specialty

Locations

About Carla C. Allan, PhD

With more than 10 years' experience in clinical psychology, Carla Allan, PhD, brings a deep sense of compassion and empathy to her work. An expert in - and passionate about - children with attention-deficit/hyperactivity disorder (ADHD), Dr. Allan expanded her focus to all aspects of pediatric mental health several years ago when she lost her sister to suicide. The experience helped solidify her "whole child-whole family" philosophy, with a focus on understanding the patients' and families' challenges while building on their strengths.

Dr. Allan joined Phoenix Children's to collaborate with a team of highly motivated mental health professionals dedicated to serving medically complex children. At Phoenix Children's, mental health experts are embedded in many of the system's medical teams to strengthen the "whole-child" commitment.

...Read more

With more than 10 years' experience in clinical psychology, Carla Allan, PhD, brings a deep sense of compassion and empathy to her work. An expert in - and passionate about - children with attention-deficit/hyperactivity disorder (ADHD), Dr. Allan expanded her focus to all aspects of pediatric mental health several years ago when she lost her sister to suicide. The experience helped solidify her "whole child-whole family" philosophy, with a focus on understanding the patients' and families' challenges while building on their strengths.

Dr. Allan joined Phoenix Children's to collaborate with a team of highly motivated mental health professionals dedicated to serving medically complex children. At Phoenix Children's, mental health experts are embedded in many of the system's medical teams to strengthen the "whole-child" commitment.

In addition, Dr. Allan and her colleagues in the Departments of Psychology and Psychiatry are working to ensure that community-based mental health care and support are available to children and families across the region, sharing their knowledge and expertise with other healthcare providers; developing community partnerships; and creating innovative system-based programs that will improve long-term outcomes.

Dr. Allan earned her bachelor's degree in psychology from Michigan State University in East Lansing, and her master's degree and doctorate in clinical psychology from Florida State University in Tallahassee. She completed her internship in clinical psychology at Children's Mercy Hospital in Kansas City, Missouri.

Dr. Allan served on the ADHD Clinical Practice Guidelines Subcommittee of the American Academy of Pediatrics and was the associate editor of the Journal of Clinical Psychology in Medical Settings. She is also a member of the Association for Behavioral and Cognitive Therapies, American Psychological Association, Society of Pediatric Psychology (SPP, APA Division 54), and Society of Clinical Child and Adolescent Psychology (SCCAP, APA Division 53).

Outside of work, Dr. Allan finds the best stress relief is playing with her two young children, ages 8 and 5. She and her family also love the outdoors, biking, hiking and camping.

Read less

+Research & Publications

Articles in Peer-Reviewed Journals:

Rogers, E.A.*, Allan, C.C., Zoromski, A., Perez Crawford, T., Moody, S.S., & Sarno Owens, J. (2022). Examining Benchmarks for the Daily Report Card Intervention in a Therapeutic Recreational Setting. Journal of Attention Disorders, 26, 1106-1117. Doi: https://doi.org/10.1177/10870547211056893<

Allan, C., DeShazer, M., Staggs, V., Nadler, C., Perez Crawford, T., Moody, S., & Chacko, A. (2021). Accidental Injuries in Preschoolers: Are We Missing an Opportunity for Early Assessment and Intervention? Journal of Pediatric Psychology, Journal of Pediatric Psychology, 46, 835-843. Doi: https://doi.org/10.1093/jpepsy/jsab044

Wolraich, M.L., Hagan, J.F., Allan, C., Chan. E., Davison, D., Earls, M., Evans, S.W., Flinn, S.K., Froehlich, T., Frost, J., Holbrook, J.R., Lehman, C.U., Lessin, H.R., Okechukwu, K., Pierce, K.L. (2019). Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents. Pediatrics, published online: September 30, 2019 (doi: 10.1542/peds.2019.2528).

Other Publications:

Matthews, B., Allan, C., Norris-Brilliant, A., Acri, M., & Chacko, A. (2020). Leveraging emerging workforces to increase ADHD service provision for children and families: Family peer Advocates as an exemplar. In R. Barkley (Ed), The ADHD Report, 28(5). New York, NY: Guilford Press.

Toolkits: Zurhellen, W., Lessin, H.R. Chan, E., Allan, C.C., Wolraich, M., Sprecher, E., & Evans, S. (2019). Caring for Children with ADHD: A Practical Resource Toolkit for Clinicians, 3rd Ed. American Academy of Pediatrics.

Principal Investigator. Modernizing Models of Care for Psychology: Can online, low-intensity support make a difference? Phoenix Children's Hospital Leadership Circle Award, $98,833. Awarded for funding period: 5/18/22-4/30-23.

Co-Principal Investigator. Development of a Universal Screening Test for Dyslexia for use in Pediatrician's Offices - Dyslexia Screening Questionnaire (DysQ). Phoenix Children's Hospital Leadership Circle Award, $149,711. Awarded for funding period: 10/1/21-9/30/21. Co-Principal Investigator: Jodi Carter, MD.

Co-Investigator. GOLDILOKS: Genomic and Ontogeny Linked Dose Individualization and CLinical Optimization for KidS. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Specialized Centers in Research in Pediatric Developmental Pharmacology (U54). The major goal of this project is to provide an arena for multidisciplinary interactions between basic and clinical scientists interested in establishing high quality translational research programs in the area of pediatric developmental pharmacology. Funding period: 8/1/2016-7/31/2021. Direct costs: $2,500,000. Principal Investigator: J. Stephen Leeder.

"
Share this page